EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Boston Scientific's Enterprise Value is $165,552 Mil.
Boston Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 was $2,723 Mil. Therefore, Boston Scientific's EV-to-FCF for today is 60.80.
The historical rank and industry rank for Boston Scientific's EV-to-FCF or its related term are showing as below:
BSX'
s EV-to-FCF Range Over the Past 10 Years
Min: -360.75 Med: 67.06 Max: 1364.82
Current: 60.8
During the past 13 years, the highest EV-to-FCF of Boston Scientific was 1364.82. The lowest was -360.75. And the median was 67.06.
BSX's EV-to-FCF is ranked worse than 74.81% of 389
companies
in the Medical Devices & Instruments industry
Industry Median: 26.23
vs BSX: 60.80
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
The historical data trend for Boston Scientific's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Boston Scientific's EV-to-FCF
For the Medical Devices subindustry, Boston Scientific's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Boston Scientific's EV-to-FCF falls into.
Boston Scientific's current Enterprise Value is $165,552 Mil.
Boston Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,723 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific (NYSE:BSX) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Boston Scientific's PE Ratio (TTM) for today is calculated as:
Boston Scientific's share price for today is $104.32.
Boston Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.370.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Boston Scientific EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Boston Scientific's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSX has been successfully added to your 